Advertisement

Inhibitory Effects of Treatment with LHRH or Its Agonists on Ovarian Receptor Levels and Function

  • Fernand Labrie
  • Claude Auclair
  • Lionel Cusan
  • André Lemay
  • Alain Bélanger
  • Paul A. Kelly
  • Louise Ferland
  • Geneviève Azadian-Boulanger
  • Jean-Pierre Raynaud
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 112)

Abstract

We have recently found that treatment of adult male rats with luteinizing hormone-releasing hormone (LHRH) or its agonists leads to a marked loss of testicular LH and prolactin receptor levels accompanied by decreased testis, seminal vesicle and prostate weight as well as lowered plasma testosterone concentration (1, 2). Since LHRH and its agonistic analogues have potent pre- and post-coital antifertility activity in the female rat (3–5) and rabbit (6), it occurred to us that these effects of LHRH and its analogues in the female could also be mediated by endogenous LH-induced desensitization of the ovary. Such a possibility was supported by the findings that treatment with LH or human chorionic gonadotropin (hCG) leads to a marked loss of LH receptors in the ovary accompanied by a reduced ability of LH to stimulate ovarian adenylyl cyclase activity (7).

Keywords

Luteal Phase Receptor Level Marked Loss LHRH Agonist Serum Progesterone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    C. Auclair, P.A. Kelly, D.H. Coy, A.V. Schally and F. Labrie, Endocrinology 101 (1977) 1890.PubMedCrossRefGoogle Scholar
  2. (2).
    G. Pelletier, L. Cusan, C. Auclair, P.A. Kelly, L. D6sy and F. Labrie, Endocrinology (1978) in press.Google Scholar
  3. (3).
    U.K. Banik and M.L. Givner. J. Reprod. Fertil. 44 (1975)87.Google Scholar
  4. (4).
    R.R. Humphrey, B.L. Windsor, F.G. Bousley and R.A. Edgren. Contraception 14(1976)625.PubMedCrossRefGoogle Scholar
  5. (5).
    A. Corbin, C.W. Beattie, J. Yorkley and T.J. Toell. Endocr. Res. Commun. 2(1976)359.CrossRefGoogle Scholar
  6. (6).
    J. Hilliard, C.N. Pang and C.H. Sawyer. Fertil. Steril. 27 (1976)421.PubMedGoogle Scholar
  7. (7).
    M. Hunzicker-Dunn and L. Birnbaumer. Endocrinology 99(1976)211.PubMedCrossRefGoogle Scholar
  8. (8).
    G.S. Kledzik, L. Cusan, C. Auclair, P.A. Kelly and F. Labrie. Fertil. Steril. 29(1973)560.Google Scholar
  9. (9).
    G.S. Kledzik, L. Fertil. Cusan, C. Auclair, P.A. Kelly and F. Labrie. (in press).Google Scholar
  10. (10).
    G.C. Olivier, J.E. Rioux and F. Labrie. Union Méd. Can. 104(1975) 403.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • Fernand Labrie
    • 1
    • 2
  • Claude Auclair
    • 1
    • 2
  • Lionel Cusan
    • 1
    • 2
  • André Lemay
    • 1
    • 2
  • Alain Bélanger
    • 1
    • 2
  • Paul A. Kelly
    • 1
    • 2
  • Louise Ferland
    • 1
    • 2
  • Geneviève Azadian-Boulanger
    • 1
    • 2
  • Jean-Pierre Raynaud
    • 1
    • 2
  1. 1.Laboratory of Molecular EndocrinologyLe Centre Hospitalier de l’Université LavalQuebecCanada
  2. 2.Centre de Recherches Roussel-UCLAFRomainvilleFrance

Personalised recommendations